7-(4-Chlorobutoxy)-2(1H)-quinolinone CAS 913613-82-8: Pharmaceutical Intermediate Supplier for CNS Disorder Treatments

Discover a critical pharmaceutical intermediate essential for developing advanced treatments for central nervous system disorders. Learn about its applications, quality standards, and reliable sourcing from a leading China manufacturer.

Get a Quote & Sample

Advantages of Sourcing 7-(4-Chlorobutoxy)-2(1H)-quinolinone

Exceptional Purity for Reliable Synthesis

Achieve superior results in your pharmaceutical synthesis with our 7-(4-Chlorobutoxy)-2(1H)-quinolinone, boasting a purity of ≥99%. This ensures minimal by-products and consistent API quality.

Strategic Pharmaceutical Intermediate

Our compound is a critical intermediate for the synthesis of Brexpiprazole and other quinoline-based pharmaceuticals, supporting the development of treatments for psychiatric conditions and CNS disorders.

Cost-Effective Supply Chain Solutions

As a Chinese manufacturer, we offer competitive pricing for 7-(4-Chlorobutoxy)-2(1H)-quinolinone, providing cost-effective solutions for your bulk procurement needs.

Key Applications in Pharmaceutical Development

Brexpiprazole Synthesis

Crucial intermediate in the multi-step synthesis of Brexpiprazole, a medication used for treating schizophrenia and depression. Purchase this key component from our trusted supplier.

CNS Disorder Therapeutics

Acts as a versatile building block for a range of quinoline-based drugs targeting central nervous system disorders, offering potential for drug discovery and development.

Pharmaceutical Research & Development

Essential for R&D in medicinal chemistry, providing a reliable starting material for exploring new therapeutic agents and optimizing existing drug candidates.

Impurity Standard Reference

Utilized as a reference standard for impurity profiling and quality control in pharmaceutical manufacturing, ensuring compliance and product safety.